又一家药企被要求退款,三叶草生物与Gavi纠纷的双重冲击与行业影响

药渡
27 Mar

来源:药渡撰文:Pharmadeep编辑:活力哈哈2025年3月21日,全球疫苗免疫联盟(Gavi)以书面通知单方面终止与三叶草生物(2197.HK)的新冠疫苗预购协议(APA),要求退还2.24亿美元预付款。三叶草生物次日公告明确拒绝,称其要求“缺乏合同依据”,并强调将通过法律手段维护权益。截至2025年3月24日,双方尚未启动正式法律程序。协议终止的潜在动因分析市场需求变化:2023年后全球...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10